Skip to main content
. 2022 Oct 2;11(10):1345. doi: 10.3390/antibiotics11101345

Table 4.

Occurrence of PJI (%) over time in knee arthroplasty group and total hip arthroplasty group according to prophylactic antibiotic.

Group Prophylactic Antibiotic 1 Month 3 Months <1 Year >1 Year
UKA/TKA Cefuroxime (n = 21), n (%) 7 (33.3) 5 (23.8) 5 (23.8) 4 (19.1)
Non-cefuroxime (n = 3), n (%) 1 (33.3) 0 (0.0) 0 (0.0) 2 (66.7)
THA Cefuroxime (n = 61), n (%) 33 (54.1) 12 (36.4) 2 (3.3) 14 (23.0)
Non-cefuroxime (n = 6), n (%) 3 (50.0) 1 (16.7) 2 (33.3) 0 (0.0.)

TKA, total knee arthroplasty; UKA, unicompartmental knee arthroplasty; THA, total hip arthroplasty; n, number.